Tissue Regenix Group plc (AIM:TRX)
London
· Delayed Price · Currency is GBP · Price in GBX 36.50
0.00 (0.00%)
Apr 17, 2025, 2:38 PM GMT+1
Tissue Regenix Group Market Cap
Tissue Regenix Group has a market cap or net worth of 26.00 million as of April 17, 2025. Its market cap has decreased by -39.96% in one year.
Market Cap
26.00M
Enterprise Value
31.00M
Revenue
25.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.50
Market Cap Chart
Since June 29, 2010, Tissue Regenix Group's market cap has decreased from 41.00M to 26.00M, a decrease of -36.59%. That is a compound annual growth rate of -3.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.00B |
| GSK plc | 54.20B |
| Haleon | 34.56B |
| Smith & Nephew | 8.59B |
| ConvaTec Group | 5.18B |
| Hikma Pharmaceuticals | 4.16B |
| HUTCHMED (China) | 1.81B |
| Oxford Nanopore Technologies | 1.12B |